COMPANY SPOTLIGHT - Teva Pharmaceutical Industries
Related Articles
- COMPANY SPOTLIGHT -- Teva Pharmaceutical Industries. // PharmaWatch: CNS;Jun2011, Vol. 10 Issue 6, p32
The article profiles world's leading generic pharmaceuticals company, Teva Pharmaceutical Industries Ltd. It provides the description of the company which offers generic products in a variety of dosage forms and is also known as the leading supplier of health care products and services. A SWOT...
- COMPANY SPOTLIGHT -- Teva Pharmaceutical Industries. // PharmaWatch: Cancer;Aug2009, Vol. 8 Issue 8, p20
The article profiles Israel-based generic pharmaceutical drugs manufacturer Teva Pharmaceutical Industries Ltd. The company has been operating in pharmaceuticals and active pharmaceutical ingredients (APIs). Teva has established research and development (R&D) units in which one focuses on the...
- Teva Pharmaceutical Industries Limited SWOT Analysis. // Teva Pharmaceutical Industries SWOT Analysis;Sep2012, p1
The article focuses on the SWOT analysis for Teva Pharmaceutical Industries Ltd., headquartered in Petach Tikva, Israel. It states that Teva's pharmaceutical manufacturing infrastructure allows it to have an extensive generic pipeline globally and a broad product line. However, the continuous...
- Teva introduces Tromethamine as generics medication. // Drug Store News;8/24/98, Vol. 20 Issue 13, pCP98
Reports on the launching of Teva Pharmaceuticals USA's generic Ketorolac Tromethamine Tablets USP 10 milligram. Cost-saving alternative; Contact information.
- Teva to Present at the Credit Suisse 2011 Healthcare Conference. // Biomedical Market Newsletter;11/14/2011, Vol. 21, p1023
The article reports that Teva Pharmaceutical Industries Ltd. will be hosting a live audio webcast during the Credit Susisse 2011 Healthcare Conference in Arizon on November 10, 2011. It mentions that chief financial officer (CFO) Eyal Desheh will be holding the live audio webcast. It also notes...
- Teva Signs $4 Bln Syndicated Credit Facilities. // Biomedical Market Newsletter;6/19/2011, p810
The article focuses on the four billion dollars syndicated credit facilities signed by Teva Pharmaceutical Industries Ltd. which supports the 6.8 billion dollars acquisition of Cephalon Inc. It says that Barclays Capital, Royal Bank of Canada, and J.P. Morgan and Morgan Stanley were also...
- Teva Announces Launch of Generic Seroquel(r) in the US. // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1
The article informs about the launch of quetiapine fumarate tablets by Teva Pharmaceutical Industries Ltd. which is the generic form of the seroquel tablets used for schizophrenia treatment manufactured by the company AstraZeneca. It informs that the company is a leading generic drug...
- Strengths. // PharmaWatch: CNS;May2012, Vol. 11 Issue 5, p20
The article presents an analysis of strengths of global provider of generic pharmaceuticals Teva Pharmaceutical Industries Ltd. It notes that there is 18% increase in revenues of Teva Pharmaceutical Industries Ltd. from 2006 to 2010. It indicates that the company is considered as the largest...
- DATAMONITOR: Teva Pharmaceutical Industries Limited. // Teva Pharmaceutical Industries SWOT Analysis;Jul2011, p1
The article presents a corporate profile of top generic pharmaceutical company Teva Pharmaceutical Industries Ltd. in Petach Tikva, Israel. The firm is engaged in the development, manufacturing and marketing of proprietary, active and generic pharmaceutical ingredients. It conducts operations in...
